Luminex, Partners HealthCare Collaborate on Biomarker, Assay Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced a deal with healthcare system Partners HealthCare for the discovery of biomarkers and development of clinical assays.

Partners HealthCare Center for Personalized Genetic Medicine will develop molecular diagnostic assays based on biomarkers discovered within the integrated health system to be run on Luminex's xMAP platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.